State Street Corporation 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-10 08:27 am Sale | 2025-09-30 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 5,617,334 4.700% | -276,024 (-4.68%) | Filing |
| 2024-01-25 10:45 am Purchase | 2023-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 5,893,358 6.010% | 848,444 (+16.82%) | Filing |
| 2023-02-03 09:51 am Purchase | 2022-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 5,044,914 5.330% | 1,059,687 (+26.59%) | Filing |
| 2022-02-09 12:49 pm Sale | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 3,985,227 4.750% | -655,696 (-14.13%) | Filing |
| 2021-02-08 10:07 am Purchase | 2020-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 4,640,923 6.560% | 2,724,961 (+142.22%) | Filing |